Rareview Capital »

SPDR S&P Biotech shares owned by Rareview Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Rareview Capital from 13F filings

Historical chart of Rareview Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Rareview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Rareview Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $410k 4.2k 98.80
2024-09-30 $453k 4.6k 98.80
2024-06-30 $425k 4.6k 92.71
2024-03-31 $398k 4.2k 94.89

More positions owned by Rareview Capital

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vaneck Etf Trust Emerging Mrkt Hi (HYEM)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Blackrock Muniyield Fund (MYD)
BlackRock MuniHoldings Fund (MHD)
Morgan Stanley Emerging Markets Domestic (EDD)
Blackrock Mun Income Tr Sh Ben Int (BFK)
Neuberger Ber. Intermediate Muni. Fund (NBH)
BlackRock Municipal Income Trust II (BLE)
Western Asset Managed Municipals Fnd (MMU)

View all positions for Rareview Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech